Fan Xiong Jing Gong Qi Wang
10.2147/OTT.S250454
Onco Targets Ther
2020 Jul 1;13:6385-6391.
brca1/2 mutations pd-l1 positive intrahepatic cholangiocarcinoma olaparib pembrolizumab
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32753881/
Case Reports
PMC7342556
32753881
Olaparib and Pembrolizumab Treatment for BRCA1-Mutated and PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Report
2020